Effect of Pegcetacoplan on Quality of Life in Patients with Paroxysmal Nocturnal Hemoglobinuria from the Pegasus Phase 3 Trial Comparing Pegcetacoplan to Eculizumab
Publication
, Conference
Roeth, A; Hoechsmann, B; Griffin, M; De Castro, CM; Szer, J; Usuki, K; Soret, J; Hamdani, M; Ajayi, T; Sarda, SP; Panse, J
Published in: BRITISH JOURNAL OF HAEMATOLOGY
2021
Duke Scholars
Published In
BRITISH JOURNAL OF HAEMATOLOGY
EISSN
1365-2141
ISSN
0007-1048
Publication Date
2021
Volume
193
Start / End Page
198 / 199
Related Subject Headings
- Immunology
- 3201 Cardiovascular medicine and haematology
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Roeth, A., Hoechsmann, B., Griffin, M., De Castro, C. M., Szer, J., Usuki, K., … Panse, J. (2021). Effect of Pegcetacoplan on Quality of Life in Patients with Paroxysmal Nocturnal Hemoglobinuria from the Pegasus Phase 3 Trial Comparing Pegcetacoplan to Eculizumab. In BRITISH JOURNAL OF HAEMATOLOGY (Vol. 193, pp. 198–199).
Roeth, Alexander, Britta Hoechsmann, Morag Griffin, Carlos M. De Castro, Jeffrey Szer, Kensuke Usuki, Juliette Soret, et al. “Effect of Pegcetacoplan on Quality of Life in Patients with Paroxysmal Nocturnal Hemoglobinuria from the Pegasus Phase 3 Trial Comparing Pegcetacoplan to Eculizumab.” In BRITISH JOURNAL OF HAEMATOLOGY, 193:198–99, 2021.
Roeth A, Hoechsmann B, Griffin M, De Castro CM, Szer J, Usuki K, et al. Effect of Pegcetacoplan on Quality of Life in Patients with Paroxysmal Nocturnal Hemoglobinuria from the Pegasus Phase 3 Trial Comparing Pegcetacoplan to Eculizumab. In: BRITISH JOURNAL OF HAEMATOLOGY. 2021. p. 198–9.
Roeth, Alexander, et al. “Effect of Pegcetacoplan on Quality of Life in Patients with Paroxysmal Nocturnal Hemoglobinuria from the Pegasus Phase 3 Trial Comparing Pegcetacoplan to Eculizumab.” BRITISH JOURNAL OF HAEMATOLOGY, vol. 193, 2021, pp. 198–99.
Roeth A, Hoechsmann B, Griffin M, De Castro CM, Szer J, Usuki K, Soret J, Hamdani M, Ajayi T, Sarda SP, Panse J. Effect of Pegcetacoplan on Quality of Life in Patients with Paroxysmal Nocturnal Hemoglobinuria from the Pegasus Phase 3 Trial Comparing Pegcetacoplan to Eculizumab. BRITISH JOURNAL OF HAEMATOLOGY. 2021. p. 198–199.
Published In
BRITISH JOURNAL OF HAEMATOLOGY
EISSN
1365-2141
ISSN
0007-1048
Publication Date
2021
Volume
193
Start / End Page
198 / 199
Related Subject Headings
- Immunology
- 3201 Cardiovascular medicine and haematology
- 1102 Cardiorespiratory Medicine and Haematology